Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand
Open Access
- 27 January 2011
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 10 (1) , 9
Abstract
Objective: To determine if a human bladder cancer-specific peptide named PLZ4 can target canine bladder cancer cells. Experimental Design: The binding of PLZ4 to five established canine invasive transitional cell carcinoma (TCC) cell lines and to normal canine bladder urothelial cells was determined using the whole cell binding assay and an affinitofluorescence assay. The WST-8 assay was performed to determine whether PLZ4 affected cell viability. In vivo tumor-specific homing/targeting property and biodistribution of PLZ4 was performed in a mouse xenograft model via tail vein injection and was confirmed with ex vivo imaging. Results: PLZ4 exhibited high affinity and specific dose-dependent binding to canine bladder TCC cell lines, but not to normal canine urothelial cells. No significant changes in cell viability or proliferation were observed upon incubation with PLZ4. The in vivo and ex vivo optical imaging study showed that, when linked with the near-infrared fluorescent dye Cy5.5, PLZ4 substantially accumulated at the canine bladder cancer foci in the mouse xenograft model as compared to the control. Conclusions and Clinical Relevance: PLZ4 can specifically bind to canine bladder cancer cells. This suggests that the preclinical studies of PLZ4 as a potential diagnostic and therapeutic agent can be performed in dogs with naturally occurring bladder cancer, and that PLZ4 can possibly be developed in the management of canine bladder cancer.Keywords
This publication has 10 references indexed in Scilit:
- Identification of a bladder cancer-specific ligand using a combinatorial chemistry approachUrologic Oncology: Seminars and Original Investigations, 2012
- Canine invasive transitional cell carcinoma cell lines: In vitro tools to complement a relevant animal model of invasive urinary bladder cancerUrologic Oncology: Seminars and Original Investigations, 2009
- Classification of Canine Urinary Bladder Urothelial Tumours Based on the World Health Organization/International Society of Urological Pathology Consensus ClassificationJournal of Comparative Pathology, 2006
- Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imagingNature Chemical Biology, 2006
- LONG-TERM BENEFIT OF 5-AMINOLEVULINIC ACID FLUORESCENCE ASSISTED TRANSURETHRAL RESECTION OF SUPERFICIAL BLADDER CANCER: 5-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED STUDYJournal of Urology, 2005
- RESTAGING TRANSURETHRAL RESECTION OF HIGH RISK SUPERFICIAL BLADDER CANCER IMPROVES THE INITIAL RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPYJournal of Urology, 2005
- Canine Transitional Cell CarcinomaJournal of Veterinary Internal Medicine, 2003
- Canine Transitional Cell CarcinomaJournal of Veterinary Internal Medicine, 2003
- Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2000
- Canine Bladder and Urethral Tumors: A Retrospective Study of 115 Cases (1980–1985)Journal of Veterinary Internal Medicine, 1992